Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.000.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.45M | 11.89M | 13.99M | 16.55M | 16.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.45M | 11.89M | 13.99M | 16.55M | 16.65M |
| Cost of Revenue | 857.00K | 931.00K | 1.08M | 1.17M | 1.20M |
| Gross Profit | 11.60M | 10.96M | 12.92M | 15.38M | 15.45M |
| SG&A Expenses | 11.05M | 11.27M | 13.49M | 14.87M | 16.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.22M | 12.62M | 15.08M | 16.69M | 18.55M |
| Operating Income | 231.00K | -728.50K | -1.09M | -134.00K | -1.89M |
| Income Before Tax | -7.48M | -7.29M | -3.97M | -4.40M | -6.42M |
| Income Tax Expenses | 9.00K | -1.00K | -581.00K | 40.00K | 29.00K |
| Earnings from Continuing Operations | -7.49 | -7.29 | -3.39 | -4.44 | -6.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.49M | -7.29M | -3.39M | -4.44M | -6.45M |
| EBIT | 231.00K | -728.50K | -1.09M | -134.00K | -1.89M |
| EBITDA | 270.00K | -699.50K | -1.07M | -113.00K | -1.87M |
| EPS Basic | -0.12 | -0.11 | -0.05 | -0.07 | -0.10 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.04 | -0.04 | -0.07 |
| EPS Diluted | -0.12 | -0.11 | -0.05 | -0.07 | -0.10 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.04 | -0.04 | -0.07 |
| Average Basic Shares Outstanding | 256.16M | 255.46M | 255.46M | 254.95M | 252.93M |
| Average Diluted Shares Outstanding | 256.16M | 255.46M | 255.46M | 254.95M | 252.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |